|1.||Galoyan, Armen: 2 articles (06/2012 - 08/2011)|
|2.||Matevosyan, M B: 1 article (09/2012)|
|3.||Seferyan, T Ye: 1 article (09/2012)|
|4.||Sargsyan, M A: 1 article (09/2012)|
|5.||Grigoryan, S L: 1 article (09/2012)|
|6.||Galoian, K A: 1 article (09/2012)|
|7.||Galoyan, A A: 1 article (09/2012)|
|8.||Durgaryan, A A: 1 article (09/2012)|
|9.||Galoian, Karina: 1 article (06/2012)|
|10.||Temple, H T: 1 article (06/2012)|
|1.||Weight Loss (Weight Reduction)
09/01/2012 - "The experimental results allow concluding that galarmin is a powerful immunomodulatory and protective agent for the in vivo prophylaxis and treatment of MRSA-induced infection."
09/01/2012 - "The protective effect of galarmin was not due to a direct effect on MRSA, but should be attributed to an action on the host response to infection. "
09/01/2012 - "Galarmin efficiently protects mice against lethal MRSA infection (100% of survival vs. 0% in the untreated group) when intramuscularly injected 24 h before infection and during the 1-h post-infection period at a concentration of 1 μg per mouse, while its higher concentrations (5 and 10 μg) were protective when injected in parallel to the infection process. "
09/01/2012 - "The protective and immunomodulatory effects of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus infection in mice."
|2.||Glycogen Synthase Kinases
|3.||Protein-Tyrosine Kinases (Tyrosine Kinase)